Summary
Latest filing:
Justin Adam Smith is Director of Journey Medical Corp (DERM). 4 SEC Form 4 filings on record going back to 2025, most recently on 2 July 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Justin Adam Smith has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Justin Adam Smith's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Daniel Allen Gold - $147.38M of ROIV open-market activity in the last 12 months
- QVT Financial LP - $147.38M of ROIV open-market activity in the last 12 months
- ULSE Inc. - $146.25M of ULS open-market activity in the last 12 months
- Andrew T. Kaplan - $134.38M of KLRA open-market activity in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M of KLRA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $133.53M of APGE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Justin Adam Smith?
Justin Adam Smith is a corporate insider, tracked as Director of Journey Medical Corp (DERM). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Justin Adam Smith submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Justin Adam Smith's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Justin Adam Smith and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
